Carlson Investments SE Highlights PUMaA TECH: AI-Powered Monitoring of Skin Lesions

WARSAW, Poland - Sept. 2, 2025 - PRLog -- Carlson Investments SE is pleased to highlight its portfolio company PUMaA TECH, a technology startup innovating in healthcare through AI and machine learning (ML). PUMaA TECH is developing a solution to help caregivers monitor and assess pressure ulcers—commonly known as bedsores—enabling faster, low-cost, and more effective evaluation of skin lesions in at-risk patients.

The PUMaA System application applies AI-driven computer vision and ML algorithms to recognize and assess the severity of pressure ulcers. Designed for non-medical caregivers as well as healthcare professionals, the solution provides actionable insights into wound condition and care options, supporting improved patient monitoring and decision-making. While not a replacement for medical professionals, PUMaA TECH empowers users with guidance for better treatment and preventive care.

Key Features of PUMaA TECH

• AI-powered diagnostics: Automated recognition of pressure ulcers using computer vision and ML.
• Accessible and easy-to-use: Designed for caregivers, requiring no medical expertise.
• Rapid assessment: Provides immediate evaluation of skin lesions.
• Innovative platform: First Polish smartphone application processing photos via neural networks for pressure ulcer monitoring.
• Scalable and adaptable: Unlimited potential for expansion and integration in healthcare systems.

Funded through the Smart Growth Operational Program 2014–2020, Measure 1.3, PUMaA TECH received PLN 880,000 in EU support for the development of this pre-seed project, with total project costs of PLN 1,100,000. The system is currently available in a test version on Google Play.

About PUMaA TECH
PUMaA TECH is a Polish technology startup committed to creating user-friendly solutions that improve patient care and support caregivers. By combining AI, ML, and mobile platforms, PUMaA TECH provides innovative tools that enhance monitoring, early detection, and preventive care for vulnerable patients.

About Carlson Investments SE

Carlson Investments SE, listed on Warsaw's NewConnect and the German Open Market (Frankfurt, Munich, Stuttgart, Gettex), supports high-growth early-stage tech ventures across healthtech, AI, fintech, and deeptech. Carlson applies a hands-on investment approach and integrates its portfolio companies into a global network of strategic partnerships.

Risk Disclaimer
This announcement • does not constitute investment advice or a solicitation to buy or sell financial instruments • involves risks, including possible loss of capital • does not guarantee future earnings • past performance is not indicative of future results.

WE ARE PUBLICLY LISTED, YOU CAN BUY OUR SHARES ON:

Warsaw Stock Exchange (PLN):   CAI, PLHOTB000011

Frankfurt Stock Exchange (EUR):   2HB (FRA), PLHOTB000011

Munich Stock Exchange (EUR):   2HB (MUN), PLHOTB000011

Stuttgart Stock Exchange (EUR):   2HB (STU), PLHOTB000011

GETTEX Exchange (EUR):   2HB (GET), PLHOTB000011

WKN:   A0RNWQ

Press Contact:

Management Office
Carlson Investments SE
ir@carlsonvc.com

www.carlsonvc.com